Why is SMS Pharma. falling/rising?

As of 20-Aug, SMS Pharmaceuticals Ltd is experiencing a slight decline in its stock price, currently at 239.45, reflecting a decrease of 0.1 or 0.04%. The stock has shown mixed performance recently, having outperformed its sector by 0.38% today, but it has also fallen after four consecutive days of gains. The stock's performance over the past week is positive at +3.21%, yet it has struggled over the longer term, with a one-month return of -4.94% and a year-to-date return of -0.17%. Despite a significant drop of -21.38% over the past year, the company's profits have increased by 28.4%, suggesting a disconnect between stock price and underlying performance. The stock is currently trading at a discount compared to its peers, with a fair valuation indicated by a ROCE of 11.5 and a PEG ratio of 1.3.
In the broader market context, SMS Pharmaceuticals Ltd's recent performance contrasts with the Sensex, which has gained 1.64% over the past week and 4.76% year-to-date. This indicates that while the stock has shown some short-term resilience, it is lagging behind the overall market performance. Additionally, the stock's liquidity appears adequate, but a notable decline in investor participation, with delivery volume dropping by 33.82% against the five-day average, may signal waning interest among investors. Overall, the combination of a recent trend reversal, declining investor participation, and the stock's underperformance relative to the benchmark suggests a cautious outlook for SMS Pharmaceuticals Ltd.